<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	>
<channel>
	<title>Comments on: HPV Vaccine (Gardasil&#169;) is Here</title>
	<atom:link href="http://www.childhoodhealth.com/archives/173/feed" rel="self" type="application/rss+xml" />
	<link>http://www.childhoodhealth.com/archives/173</link>
	<description>Pediatric clinic in Oregon committed to quality health care.</description>
	<lastBuildDate>Tue, 01 Dec 2009 21:36:15 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=abc</generator>
	<item>
		<title>By: Kenneth Carlson, MD</title>
		<link>http://www.childhoodhealth.com/archives/173/comment-page-1#comment-2591</link>
		<dc:creator>Kenneth Carlson, MD</dc:creator>
		<pubDate>Fri, 26 Jan 2007 06:54:17 +0000</pubDate>
		<guid isPermaLink="false">http://www.childhoodhealth.com/archives/173#comment-2591</guid>
		<description>EU has approved Gardasil. More information at: http://news.bbc.co.uk/2/hi/health/5370504.stm

I am not aware of data in its use in immuncompromised patients. With all vaccines it is best to discuss with your doctor if such a vaccine is best for you. In general if a vaccine is not contraindicated for a person with a particular condition it is given at the recommend dosages and schedule. If there is question of its immunigenicity than testing can be done after the series is completed to assess effectiveness.

An excellent resource for immunization questions not answered by usual information is to go directly to the experts from the CDC - National Immunization Program. They can be reached by email at NIPINFO@cdc.gov or 1-800-CDC-INFO.</description>
		<content:encoded><![CDATA[<p>EU has approved Gardasil. More information at: <a href="http://news.bbc.co.uk/2/hi/health/5370504.stm" rel="nofollow">http://news.bbc.co.uk/2/hi/health/5370504.stm</a></p>
<p>I am not aware of data in its use in immuncompromised patients. With all vaccines it is best to discuss with your doctor if such a vaccine is best for you. In general if a vaccine is not contraindicated for a person with a particular condition it is given at the recommend dosages and schedule. If there is question of its immunigenicity than testing can be done after the series is completed to assess effectiveness.</p>
<p>An excellent resource for immunization questions not answered by usual information is to go directly to the experts from the <span class="caps">CDC </span>- National Immunization Program. They can be reached by email at <span class="caps">NIPINFO</span>@cdc.gov or 1-800-CDC-INFO.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: doug maclean</title>
		<link>http://www.childhoodhealth.com/archives/173/comment-page-1#comment-2582</link>
		<dc:creator>doug maclean</dc:creator>
		<pubDate>Thu, 25 Jan 2007 23:54:48 +0000</pubDate>
		<guid isPermaLink="false">http://www.childhoodhealth.com/archives/173#comment-2582</guid>
		<description>Is Gardisil available yet in the UK?
Do patients with CKD5 ( End stage renal failure ) require larger doses of vaccine akin to that seen in this cohort of patients when being vaccinated against Hepatitis B? Are there data available on antibody reponses</description>
		<content:encoded><![CDATA[<p>Is Gardisil available yet in the UK?<br />
Do patients with <span class="caps">CKD5 </span>( End stage renal failure ) require larger doses of vaccine akin to that seen in this cohort of patients when being vaccinated against Hepatitis B? Are there data available on antibody reponses</p>
]]></content:encoded>
	</item>
</channel>
</rss>
